Compare FDC LTD. with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. DIVIS LABORATORIES FDC LTD./
DIVIS LABORATORIES
 
P/E (TTM) x 18.0 32.1 56.0% View Chart
P/BV x 2.4 7.2 33.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 FDC LTD.   DIVIS LABORATORIES
EQUITY SHARE DATA
    FDC LTD.
Mar-18
DIVIS LABORATORIES
Mar-18
FDC LTD./
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3191,142 27.9%   
Low Rs164533 30.8%   
Sales per share (Unadj.) Rs61.6146.6 42.1%  
Earnings per share (Unadj.) Rs9.933.0 30.1%  
Cash flow per share (Unadj.) Rs12.038.4 31.2%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.2 0.0%  
Book value per share (Unadj.) Rs73.2222.8 32.8%  
Shares outstanding (eoy) m174.40265.47 65.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.95.7 68.6%   
Avg P/E ratio x24.325.3 95.8%  
P/CF ratio (eoy) x20.221.8 92.6%  
Price / Book Value ratio x3.33.8 87.8%  
Dividend payout %030.3 0.0%   
Avg Mkt Cap Rs m42,118222,318 18.9%   
No. of employees `0005.510.8 51.4%   
Total wages/salary Rs m2,1674,561 47.5%   
Avg. sales/employee Rs Th1,943.73,616.0 53.8%   
Avg. wages/employee Rs Th391.7423.8 92.4%   
Avg. net profit/employee Rs Th313.7814.9 38.5%   
INCOME DATA
Net Sales Rs m10,75138,915 27.6%  
Other income Rs m5101,134 44.9%   
Total revenues Rs m11,26040,049 28.1%   
Gross profit Rs m2,26712,617 18.0%  
Depreciation Rs m3511,425 24.7%   
Interest Rs m1413 105.3%   
Profit before tax Rs m2,41112,313 19.6%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6713,543 18.9%   
Profit after tax Rs m1,7358,770 19.8%  
Gross profit margin %21.132.4 65.0%  
Effective tax rate %27.828.8 96.7%   
Net profit margin %16.122.5 71.6%  
BALANCE SHEET DATA
Current assets Rs m7,21345,351 15.9%   
Current liabilities Rs m2,1046,507 32.3%   
Net working cap to sales %47.599.8 47.6%  
Current ratio x3.47.0 49.2%  
Inventory Days Days54127 43.0%  
Debtors Days Days2895 29.1%  
Net fixed assets Rs m6,86521,160 32.4%   
Share capital Rs m175531 33.0%   
"Free" reserves Rs m12,58658,625 21.5%   
Net worth Rs m12,76159,156 21.6%   
Long term debt Rs m60-   
Total assets Rs m15,04167,832 22.2%  
Interest coverage x173.2926.8 18.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 124.6%   
Return on assets %11.612.9 89.8%  
Return on equity %13.614.8 91.7%  
Return on capital %19.020.8 91.0%  
Exports to sales %12.30-   
Imports to sales %021.8 0.0%   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNA8,485 0.0%   
Fx inflow Rs m1,88932,359 5.8%   
Fx outflow Rs m09,042 0.0%   
Net fx Rs m1,88923,317 8.1%   
CASH FLOW
From Operations Rs m1,4987,759 19.3%  
From Investments Rs m201-4,783 -4.2%  
From Financial Activity Rs m-1,694-3,142 53.9%  
Net Cashflow Rs m10-166 -6.2%  

Share Holding

Indian Promoters % 68.9 52.0 132.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 11.8 39.8%  
FIIs % 7.5 19.0 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.2 110.5%  
Shareholders   23,730 31,796 74.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   BIOCON   WOCKHARDT  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare FDC LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Rally; Sensex Zooms 1,250 Points(12:30 pm)

Share markets in India are presently trading on a strong note, cheering the government's move to cut corporate tax rates to boost economic growth.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 23, 2019 02:19 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - UNICHEM LAB COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS